Sysmex (OTCMKTS:SSMXY) Shares Gap Up - Still a Buy?

Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) shares gapped up before the market opened on Monday . The stock had previously closed at $16.76, but opened at $17.35. Sysmex shares last traded at $17.10, with a volume of 6,441 shares changing hands.

Sysmex Stock Up 0.8%

The company has a debt-to-equity ratio of 0.12, a current ratio of 2.97 and a quick ratio of 2.30. The firm has a market cap of $10.78 billion, a price-to-earnings ratio of 30.57 and a beta of 1.14. The firm has a 50 day moving average price of $17.45 and a 200-day moving average price of $18.21.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last issued its quarterly earnings results on Wednesday, May 14th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.04). Sysmex had a net margin of 10.56% and a return on equity of 11.81%. The firm had revenue of $958.89 million for the quarter, compared to analyst estimates of $991.22 million. As a group, equities analysts predict that Sysmex Corporation ADR will post 0.57 EPS for the current fiscal year.

Sysmex Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.